Thr210

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Thr210 - VAV3 (human)

Site Information
TEEkytEtLEsIEKy SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 23072229

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 )
Disease tissue studied:	lung cancer ( 1 ) , non-small cell lung cancer ( 1 ) , non-small cell large cell lung carcinoma ( 1 )
Relevant cell line - cell type - tissue:	NCI-H661 (pulmonary) ( 1 )

References
1	Rikova K (2011) CST Curation Set: 10897; Year: 2011; Biosample/Treatment: cell line, NCI-H661/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]) Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.